$1.67
-0.01-0.60%
Comments
Loading...
Latest Chemomab Therapeutics Stock News | NASDAQ:CMMB | Benzinga
Get the latest news on Chemomab Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Chemomab Therapeutics performance
Categories: All
Thursday, February 20, 2025
Wednesday, February 19, 2025
Friday, November 15, 2024
Thursday, November 14, 2024
Tuesday, October 15, 2024
Tuesday, September 03, 2024
Wednesday, August 21, 2024
Friday, July 26, 2024
Thursday, July 25, 2024
Tuesday, June 25, 2024
Thursday, June 06, 2024
Monday, May 13, 2024
Thursday, May 09, 2024
Wednesday, May 08, 2024
Monday, May 06, 2024
Thursday, April 18, 2024
Monday, March 25, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Tuesday, February 20, 2024
Tuesday, January 30, 2024
Thursday, January 18, 2024
Wednesday, January 03, 2024
Tuesday, December 19, 2023
Thursday, November 16, 2023
Wednesday, November 15, 2023
- Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
- Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Chemomab Therapeutics shares are trading high...
- US Stocks Gain; Producer Prices Fall In October
- Why is Liver Disease Focused Chemomab Stock Trading Higher Today?